1. Identification of hub genes associated with cognition in the hippocampus of Alzheimer's Disease.
- Author
-
Liu YJ, Liu TT, Jiang LH, Liu Q, Ma ZL, Xia TJ, and Gu XP
- Subjects
- Animals, Disease Models, Animal, Male, Mice, Mice, Transgenic, Alzheimer Disease genetics, Alzheimer Disease metabolism, Calbindin 1 biosynthesis, Calbindin 1 genetics, Cognition, Hippocampus metabolism, Receptor-Interacting Protein Serine-Threonine Kinase 2 biosynthesis, Receptor-Interacting Protein Serine-Threonine Kinase 2 genetics, Tachykinins biosynthesis, Tachykinins genetics
- Abstract
Alzheimer's Disease (AD) is a neurodegenerative disease featured by cognitive impairment. This bioinformatic analysis was used to identify hub genes related to cognitive dysfunction in AD. The gene expression profile GSE48350 in the hippocampus of AD patients aged >70 years was obtained from the Gene Expression Omnibus (GEO) database. A total of 96 differentially expressed genes (DEGs) were identified, and subjected to Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses; a protein-protein interaction (PPI) network was constructed. The DEGs were enriched in synapse-related changes. A protein cluster was teased out of PPI. Furthermore, the cognition ranked the first among all the terms of biological process (BP). Next, 4 of 10 hub genes enriched in cognition were identified. The function of these genes was validated using APP/PS1 mice. Cognitive performance was validated by Morris Water Maze (MWM), and gene expression by RT-qPCR, Cholecystokinin ( CCK ), Tachykinin precursor 1 ( TAC1 ), Calbindin 1 ( CALB1 ) were downregulated in the hippocampus. These genes can provide new directions in the research of the molecular mechanism of AD.
- Published
- 2021
- Full Text
- View/download PDF